Iceland· IS-EU/1/12/815/001-006
Selincro
A nalmefene product containing nalmefenum inn, registered in Iceland by H. Lundbeck A/S*. The same ATC class is registered in 14 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Nalmefene is registered in 14 of 19 countries.
Countries holding a registration under ATC N07BB05 (nalmefene), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 9 of them publish a price we can compare per daily dose
Nalmefene · ATC N07BB05
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nalmefene costs, country by country.
Normalised to the WHO defined daily dose (18 mg), the median price runs from $3.31 in France to $6.33 in Switzerland — a ×1.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nalmefene · price per daily dose (18 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.33
- FR France$3.31
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Nalmefenum INN
- Manufacturer
- H. Lundbeck A/S*
- Country
- Iceland (IS)
- ATC code
- N07BB05
- ATC class
- Nalmefene
- Defined daily dose
- 18 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 2
2 priced- ean13860328 stk x1 þpakkiISK 23356
- ean58010414 stk x1 þpakkiISK 12582
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for nalmefene.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nalmefene · interactions on record
5 records
- 4 moderate
- 1 minor
Most severe, free to view
- Methylnaltrexone bromideA06AH01moderate
- NaloxegolA06AH03moderate
- NaldemedineA06AH05moderate
- GlimepirideA10BB12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nalmefene in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSELINCROH. Lundbeck A/S, Valby
- SpainSELINCRO 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULAH. Lundbeck A/S
- SwitzerlandSelincro, FilmtablettenLundbeck (Schweiz) AG
- IrelandSelincro 18 mg film-coated tabletsH. Lundbeck A/S
- NetherlandsSelincro 18 mg, filmomhulde tabletH. Lundbeck A/S
- NorwaySelincroH.Lundbeck
- PolandSelincroH. Lundbeck A/S
- BelgiumSelincro 18 mgH. Lundbeck
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Nalfino
- France · Nalmefene Biogaran
- Norway · Selincro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d68aaf3b-98c7-4d17-9432-90c02c8ef894 GET /v1/drugs/d68aaf3b-98c7-4d17-9432-90c02c8ef894?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "N07BB05",
"marketed": true,
"strength": "18 mg",
"ma_number": "EU/1/12/815/001-006",
"substance": "Nalmefenum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "41330"
}See everything about nalmefene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.